A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis

Update Il y a 4 ans
Reference: NCT00479427

Woman and Man

Extract

This is a double-blind, two-period, placebo controlled cross-over Phase IIa study. This study is to use CB2 compound of GW842166 in patients with osteoarthritis. The pain assessments and WOMAC questionnaires will be used in the study after the repeated dose to evaluate the efficacy of CB2 compound of GW842166.


Inclusion criteria

  • Osteoarthritis

Links